The central dogma of mammalian brain sexual differentiation has contended that sex steroids of gonadal origin organize the neural circuits of the developing brain [1] . Recent evidence has begun to challenge this idea and has suggested that, independent of the masculinizing effects of gonadal secretions, XY and XX brain cells have different patterns of gene expression that influence their differentiation and function [2] . We have previously shown that specific differences in gene expression exist between male and female developing brains and that these differences precede the influences of gonadal hormones [3] . Here we demonstrate that the Y chromosome-linked, male-determining gene Sry is specifically expressed in the substantia nigra of the adult male rodent in tyrosine hydroxylase-expressing neurons. Furthermore, using antisense oligodeoxynucleotides, we show that Sry downregulation in the substantia nigra causes a statistically significant decrease in tyrosine hydroxylase expression with no overall effect on neuronal numbers and that this decrease leads to motor deficits in male rats. Our studies suggest that Sry directly affects the biochemical properties of the dopaminergic neurons of the nigrostriatal system and the specific motor behaviors they control. These results demonstrate a direct male-specific effect on the brain by a gene encoded only in the male genome, without any mediation by gonadal hormones.
Summary
The central dogma of mammalian brain sexual differentiation has contended that sex steroids of gonadal origin organize the neural circuits of the developing brain [1] . Recent evidence has begun to challenge this idea and has suggested that, independent of the masculinizing effects of gonadal secretions, XY and XX brain cells have different patterns of gene expression that influence their differentiation and function [2] . We have previously shown that specific differences in gene expression exist between male and female developing brains and that these differences precede the influences of gonadal hormones [3] . Here we demonstrate that the Y chromosome-linked, male-determining gene Sry is specifically expressed in the substantia nigra of the adult male rodent in tyrosine hydroxylase-expressing neurons. Furthermore, using antisense oligodeoxynucleotides, we show that Sry downregulation in the substantia nigra causes a statistically significant decrease in tyrosine hydroxylase expression with no overall effect on neuronal numbers and that this decrease leads to motor deficits in male rats. Our studies suggest that Sry directly affects the biochemical properties of the dopaminergic neurons of the nigrostriatal system and the specific motor behaviors they control. These results demonstrate a direct male-specific effect on the brain by a gene encoded only in the male genome, without any mediation by gonadal hormones.
Results and Discussion

Localization of SRY in the Brain
To examine the expression of Sry mRNA in the adult mouse brain, we analyzed consecutive coronal sections by radioactive in situ hybridization. Specific labeling of Sry was observed in the substantia nigra (SN) of the midbrain and the medial mammillary bodies (MMB) of the hypothalamus of male, but not female, mice ( Figures  1A-1C ). Lower levels of Sry expression were observed sparsely throughout the cortex. Primers that distinguish between circular and linear Sry mRNA forms were used [4] in RT-PCR, confirming that Sry mRNA transcripts in the midbrain and cortex of the adult male brain were of the linear form (data not shown). Examination of brains of male and female Sry-enhanced green fluorescent protein (EGFP) transgenic adult mice, in which 7.7 kb of the Sry promoter drives the expression of the reporter EGFP [5] , also revealed positive Sry expression in the SN (Figures 1D and 1E ). This observation confirms our in situ hybridization results and suggests that regulatory sequences for brain expression of Sry are contained within 7.7 kb of the start transcription. These data are consistent with previous reports of Sry expression in the adult mouse hypothalamus, midbrain, and cortex [6, 7] but provide a detailed survey of its expression.
Sry protein was observed in all regions of the SN, with most SRY immunoreactive cells in the pars compacta region of adult male mouse ( Figure 1F [SNc]) and rat brains ( Figure S1 ). Sry staining was observed in both the cytoplasm and the nucleus of cells; the nucleus is the presumed site of action of SRY as a DNA binding transcription factor. To determine whether SRY was colocalized with tyrosine hydroxylase (TH) in the SN, we performed double-label immunohistochemistry for SRY and TH ( Figure 1F ). Ten percent of all cells (DAPI stained) were SRY positive. All SRY-positive cells were also TH-positive neurons. Thus, SRY protein is produced in the adult male mouse SN and is localized exclusively in TH-positive neurons. Sry staining was absent in the female mouse SN. (Figure 1G ).
Before evaluating the role of Sry function in the SN, we first tested whether the number of TH neurons in the rat SN was sexually dimorphic. In females, the number of TH-ir neurons was 20% less than the number in agematched male controls ( Figure 2C , p = 0.032). This indicates that the expression of TH, the rate-limiting enzyme of the dopaminergic pathway, is sexually dimorphic in rats, which correlates with previous findings in mice [8] .
Effects of Sry on TH Neurons in the SN and Striatum
To investigate the effect of Sry on TH neurons in vivo and consequent motor behavior in rats, we specifically downregulated Sry in the SN by an antisense targeting method [9] . Sry antisense oligodeoxynucleotides (ODN; see Table 1 ) were microinfused unilaterally into the SNs of male rats. As a control, the contralateral SN was infused with Sry sense ODN. Infusion of Sry Figure 2E ), suggesting that the Sry antisense cocktail used in this study was specific for the Sry gene. These results suggest that the reduction of TH-positive neurons in males was due to a reduction in TH expression rather than a loss of TH-ir neurons.
TH neurons in the SN project to the striatum and provide dopamine innervation. Thus, we tested whether Sry antisense ODN infusions in the SN altered TH immunostaining in the striatum. Quantification of striatal TH-ir by optical density demonstrated that treatment with antisense ODN reduced TH immunostaining 26% in comparison to SRY sense control sides ( Figure 2F , p = 0.042).
To demonstrate that the Sry actions on TH neurons observed in our studies were specific, we investigated whether the expression of Nur-related factor 1 (Nurr1) was affected by our ODN infusions. Nurr1 is expressed in the midbrain of developing mice at embryonic day 10.5, a time before TH is detected, and continues to be expressed into adulthood. In Nurr1 knockout mice, developing neurons do not acquire dopaminergic markers such as TH, and they ultimately die as development progresses [11, 12] . Using adjacent brain slides that have shown differences in TH-ir in the SN, we did not observe any differences between antisense-Sry-ODNinfused brains and sense-ODN-infused brains (data not shown) when we performed immunostaining with Nurr1 antibody, suggesting that Sry does not directly affect the expression of Nurr1.
SRY Effects on Sensorimotor Function
A decrease in SN dopamine causes quantifiable deficits in sensorimotor function [13] . The effect of Sry antisense ODN in the SN on specific motor functions was assessed by the akinesia and limb-use asymmetry tests [14] . In the akinesia test, animals with unilateral dopamine depletions take fewer steps with their forelimb contralateral to the depletion than they do with their ipsilateral forelimb. Unilateral Sry antisense infusions reduced the number of steps taken by the contralateral forelimbs by 58.8% (Table 2) . A pre-ODN infusion I 2 C (ipsilateral minus contralateral) score of 0.2 almost reflected equal usage of both forelimbs in stepping when individual limbs were examined. However, after ODN infusion, animals stepped more readily when ipsilateral limbs were isolated, as represented by a significant positive I 2 C of 10.4, suggesting a statistically significant deficit in contralateral limb usage ( Figure 3A , p < 0.001). In addition, animals with unilateral Sry antisense ODN infusions exhibited a similar decrease in TH expression in the SN, and this decrease was associated with asymmetrical limb usage. In this test, we observed a 26.4% decrease in contralateral limb usage after infusion of Sry antisense ODN ( Table 2 ). The negative I 2 C score during pre-ODN infusion trials (229.6 6 13.2) indicated an inherent bias by the animals toward favoring their contralateral limb during cylinder exploration. However, the tendency of limb usage switched to significantly favoring the ipsilateral limb that was associated with sense ODN treatments during post-ODN trials ( Figure 3B , p = 0.013). Both sets of behavior tests exhibited similar trends where animals uniformly decreased their contralateral limb usage and began 64.8 6 6.6 35.2 6 6.6 229.6 6 13.2 42.4 6 9.6 57.6 6 9.6 15. favoring the use of their ipsilateral limbs. These data suggest that Sry downregulation in the SN reduces motor behaviors and are entirely consistent with the effect of Sry on TH expression in the nigrostriatal system. To verify that the decrease in TH-ir neurons in the SN, and the consequent motor-behavior deficit observed in our rats, were not attributed to generalized neurotoxicity brought about by the administration of antisense ODN, we assessed animals for motor behavior 7 days after termination of the antisense ODN treatment. Because the effect of the ODN should be transient, some, if not all, recovery of both the activity of the Sry gene product and motor behavior should occur. Using the akinesia test, we observed no difference in contralateral or ipsilateral limb usage when the I 2 C value returned to near zero (20.5 6 0.7) ( Figure 3A , p = 0.001) after 7 days of no ODN infusions, indicating a complete recovery in contralateral limb usage.
Conclusions
The experiments described here provide evidence that the testis-determining gene Sry is expressed and translated in specific regions of the male mammalian adult brain and that its role in the SN is to maintain biochemical and motor functions of dopaminergic neurons. These regions interestingly correspond to areas of the brain that are subject to sexual differentiation [15] . Modulation of TH expression is complex and involves transcriptional control, alternative RNA processing, and regulation of RNA stability [16] . Our data indicate that Sry may control TH expression in the SN via both direct and indirect mechanisms. Direct transcriptional control of TH by Sry is possible in a subset of cells co-expressing the proteins and is supported by the reported Srymediated activation of the TH gene promoter and by in vitro transfection experiments [17] . Sry might act to increase the number of TH-positive neurons in the SN to a male level. When Sry is absent, as is the case in females, the number of TH-positive neurons remains at a lower level. However, this does not explain why downregulation of Sry causes nigrostriatal deficits because females do not exhibit overt motor dysfunction. An alternative view is that Sry could compensate for a factor that is only present in females and maintains TH expression in SN neurons. Estrogens have been shown to influence TH in dopaminergic neurons: Short-term administration of estradiol benzoate increases the levels of TH in dopaminergic neurons [18] , and short-term ovariectomy results in a reversible decrease in the number of TH-positive neurons [19] . The role of Sry in the brain, to generate sex differences in behavior, as well as to compensate for other (e.g., hormonally induced) sex differences [20] , is consistent with the dual-function hypothesis for neural sex differences [21] . The precise molecular mechanisms by which Sry affects dopaminergic neurons remain to be elucidated. Demonstration of a specific function for Sry in the SN may provide a new model for a direct genetic effect on a brain sexual dimorphism that is not mediated by the effects of gonadal hormones. 
